BU biolab gets approval for research on deadliest pathogens
The Centers for Disease Control and Prevention has approved a Biosafety Level 4 laboratory to operate on Boston University’s medical campus in the South End, according to the Boston Public Health Commission.
Scientists in the National Emerging Infectious Diseases lab would have clearance to study the world’s deadliest pathogens, such as Ebola. The biolab still needs to win approval from the city’s health commission before that research can begin.
Read the complete story at BostonGlobe.com.
Don’t have a Globe subscription? Boston.com readers get a 2-week free trial.
To comment, please create a screen name in your profile
To comment, please verify your email address
Conversation
This discussion has ended. Please join elsewhere on Boston.com